@zklaassen_md@DrSpratticus@urotoday I missed this presentation. Does Luminal type remain significant if controlled for Gleason’s score on multivariate analysis?
Interesting to see audience answers to "What's the biggest barrier you face in addressing health disparities at work?"
#ASTRO25
Curious what others, not in the room, believe are the barriers
#bcsm#gyncsm#lcsm#crcsm#healthequity
@yuanjamesrao Congratulations to these brave investigators standing up to answer whether protons are in any way superior to IMRT in prostate cancer. Efficacy is same, now the value equation should include cost comparisons.
Congratulations to the newly elected members of ASTRO’s Board of Directors. The new officers’ terms will begin on October 1 at the #ASTRO24 Annual Meeting. https://t.co/DYgSZxpKZa
@NehaVapiwala@DrMalikaSiker@SBRT_CR@JeanMoranPhD
ACCC is thrilled to announce @Ted A. James, MD, MHCM, FACS, as the opening keynote speaker at #ACCCNOC. Join us from October 4–6 in Austin, Texas, to hear this inspiring talk on how transformative leaders empower and engage teams.
Register: https://t.co/AoDoX1g5Od
@DrSpratticus Do You Think the NCCN will finally abandon combo EBRT-Seeds for unfavorable intermediate risk prostate cancer with RTOG 0232 confirming no added benefit of EBRT? https://t.co/3smJILEZw0
In an interview with Targeted Oncology, Matthew Manning, MD, FASTRO, discussed the many radiation #oncology tasks that have been improved with AI and its prospective utility in #cancer diagnosis and treatment decisions. @isculapius
https://t.co/AnCrvmY71x
Andre Harvin, PharmD makes a great argument and demonstrates the value of oncology pharmacists and the impact they can have clinically, operationally, and financially for cancer centers. #AMCCBS
Moses Cone Hospital has been named the best hospital in North Carolina by Business North Carolina magazine! This is the second consecutive year and the third time in five years the hospital has received this ranking. Learn more: https://t.co/TMkUFpPMsT
Roshan Prabhu presenting impressive multi-center data with low local failure, nodular meningeal failure and ARE on 400+(!) patients treated with pre-op SRS @ASTRO_org#ASTRO22 for #brainmets - a technique pioneered @LevineCancer@AtriumHealth and led to just opened @NRGonc BN-012